The Mesothelioma Guide Blog

Peritoneal mesothelioma, a cancer of the abdominal lining, often deceives doctors, patients and more of its presence. The main reason for this is the signs of peritoneal...

Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form...

With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate...

Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a...

The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of...

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...

Treatment for peritoneal mesothelioma is today where treatment was three years ago for pleural mesothelioma. Tumor treating fields are not yet acceptable for non-surgical cases....

There are various types of immunotherapy. Could pairing two of them work for malignant mesothelioma? A new study out of the National Cancer Institute is combining an immune...

The next chapter in the Johnson & Johnson asbestos saga is almost written. It might be defined by one word: bankruptcy. According to reports from the Wall Street Journal and...